News | April 22, 2023
CCI approves Berhyanda's acquisition of Suven Pharma
The acquisition would be by way of a share purchase agreement dated Dec. 26, 2022.
The acquisition would be by way of a share purchase agreement dated Dec. 26, 2022.
With a focus on optimizing patient experience with next-generation oral dosage forms, the US facility complements the cutting-edge research activities of Roquette’s existing pharma innovation centers in France and Singapore
SÜDPACK is setting standards in terms of both performance and sustainability
Bayer reported the highest market capitalization growth of 23.1% during Q1 2023
Showcased digital innovations: MyPKFit, SYNAPSE and Athena at the G20 Health Working Group Meeting
Marksans will continue to supply existing products until the end of 2023 to Teva's affiliates, ensuring high-quality standards
This plant adds around 60,000 MT of capacity, scaling Jubilant Ingrevia Limited’s overall annual Acetic Anhydride capacity to 210,000 MT
Everest and SPH Kyuan will work closely to promote import and channel distribution of XERAVA in China
Franson will help biopharma clients design a phased approach to inform and execute clinical development plans
The data highlight the three drug candidates' potential for clinical development and promising synergistic utilities in new indications
Subscribe To Our Newsletter & Stay Updated
